1,2-dithiol-3-thione has been researched along with Psoriasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, DA; Chu, MY; Hung, YH; Liu, CT; Song, YC; Tang, YH; Wu, PY; Yen, HR; Yen, JJ | 1 |
| Chen, YC; Chou, TY; Li, CL; Liao, EC; Lu, LY; Shih, MC; Wang, KC; Yen, CY; Yen, LJ; Yu, SJ | 1 |
2 other study(ies) available for 1,2-dithiol-3-thione and Psoriasis
| Article | Year |
|---|---|
Targeting Nrf2 with 3 H-1,2-dithiole-3-thione to moderate OXPHOS-driven oxidative stress attenuates IL-17A-induced psoriasis.
Topics: Animals; Antioxidants; Interleukin-17; Keratinocytes; Mice; NF-E2-Related Factor 2; Oxidative Stress; Psoriasis; Quality of Life | 2023 |
Inhibition of NLRP3 Inflammasome Activation by 3H-1,2-Dithiole-3-Thione: A Potential Therapeutic Approach for Psoriasis Treatment.
Topics: Animals; Caspase 1; Inflammasomes; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Psoriasis; Quality of Life | 2023 |